Difficult diagnosis: The Stewart-Treves syndrome vs. Kaposi sarcoma following mastectomy for breast cancer - A case report
Abstract
##plugins.themes.bootstrap3.article.details##
Stewart - Treves syndrome, Kaposi sarcoma, lymphangiosarcoma, lymph edema, mastectomy
2. Laguerre B, Lefeuvre C, Kerbrat P, Hassel M. Stewart-Treves syndrome arising in posttraumatic lymphedema. Bull Cancer 1999; 86(3):279-282.
3. Fodor J, Orosz Z, Szabo E, et al. Angiosarcoma after conservation treatment for breast carcinoma: our experience and a review of the literature. J Am Acad Dermatol 2006; 54:499–504.
4. Vojtísek R, Kinkor Z, Fínek J. Secondary angiosarcomas after conservation treatment for breast cancers. Klin Onkol 2011; 24(5):382-388.
5. Lee SB, Cho BK, Houh W, Song YT, Shim SI, Choi IB. A case of Stewart-Treves syndrome. J Korean Med Sci 1988; 3(2):83–88.
6. Caldwell JB, Ryan MT, Benson PM, James WD. Cutaneous angiosarcoma arising in the radiation site of a congenital hemangioma. J Am Acad Dermatol 1995; 33(5 Pt 2):865-870.
7. Sharma A, Schwartz RA. Stewart-Treves syndrome: pathogenesis and management. J Am Acad Dermatol 2012; 67(6):1342-1348.
8. Strobbe LJ, Peterse HL, van Tinteren H, Wijnmaalen A, Rutgers EJ. Angiosarcoma of the breast after conservation therapy for invasive cancer, the incidence and outcome. An unforeseen sequela. Breast Cancer Res Treat 1998; 47(2):101-109.
9. Dürr HR, Pellengahr C, Nerlich A, Baur A, Maier M, Jansson V. Stewart-Treves syndrome as a rare complication of a hereditary lymphedema. Vasa 2004; 33(1):42-45.
10. Hallel-Halevy D, Yerushalmi J, Grunwald MH, Avinoach I, Halevy S. Stewart-Treves syndrome in a patient with elephantiasis. J Am Acad Dermatol 1999; 41(2):349-350.
11. Hulme SA, Bialostocki A, Hardy SL, Tills MR. Stewart-Treves syndrome in a congenitally lymphedematous upper limb. Plast Reconstr Surg 2007; 119(3):1140-1141.
12. Komorowski AL, Wysocki WM, Mitus J. Angiosarcoma in a chronically lymphedematous leg: An unusual presentation of Stewart-Treves syndrome. South Med J 2003; 96(8):807-808.
13. Ron IG, Amir G, Marmur S, Chaitchik S, Inbar MJ. Kaposi's Sarcoma on a lymphedematous arm after mastectomy. Am J Clin Oncol 1996; 19(1):87-90.
14. Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 2000; 13(2):180–185.
15. Ruocco E, Ruocco V, Tornesello ML, Gambardella A, Wolf R, Buonaguro FM. Kaposi's sarcoma: etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Controversies in Dermatology: Part IV 2013; 31(4):413-422.
16. Mallon E, Powell S, Mortimer P, Ryan TJ. Evidence for altered cell-mediated immunity in postmastectomy lymphoedema. Br J Dermatol 1997; 137:928–933.
17. Mankey CC, McHugh JB, Thomas DG, Lucas DR. Can lymphangiosarcoma be resurrected? A clinicopathological and immune-histochemical study of lymphatic differentiation in 49 angiosarcomas. Histopathology 2010; 56(3):364-371.
18. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol 2008, 3:31-42.
19. Lee∙KB, Lee HS, Lee HE, et al. Immunohistochemical characteristics of Kaposi sarcoma and its mimicries. Korean J Pathol 2006; 40(5):361-367.
20. Allan AE, Shoji T, Li N, Burlage A, Davis B, Bhawan J. Two cases of Kaposi's sarcoma mimicking Stewart-Treves syndrome found to be human herpesvirus-8 positive. Am J Dermatopathol 2001; 23(5):431-436.
21. Cheuk W, Wong KOY, Wong CSC, Dinkel JE, Ben-Dor D, Chan JKC. Immunostaining for human herpesvirus 8 latent nuclear antigen-1 helps distinguish Kaposi sarcoma from its mimickers. Am J Clin Pathol 2004; 121(3):335-342.
22. Rutgers JL, Wieczorek R, Bonetti F, et al. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma: evidence for a vascular endothelial cell origin. Am J Pathol 1986; 122(3):493–499.
23. Facchetti F, Lucini L, Gavazzoni R, Callea F. Immunomorphological analysis of the role of blood vessel endothelium in the morphogenesis of cutaneous Kaposi's sarcoma: a study of 57 cases. Histopathology 1988; 12(6): 581–593.
24. Jussila L, Valtola R, Partanen TA, et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.Cancer Res 1998; 58(8):1599–1604.
25. Lymboussaki A, Partanen TA, Olofsson B, et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 1998; 153(2): 395–403.
26. Sauter B, Foedinger D, Sterniczky B, Wolff K, Rappersberger K. Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells: differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human skin, lymphangioma, and hemangioma in situ. J Histochem Cytochem 1998; 46(2):165–176.
27. Grobmyer SR, Daly JM, Glotzbach RE, Grobmyer AJ 3rd. Role of surgery in the management of postmastectomy extremity angiosarcoma (Stewart-Treves syndrome). J Surg Oncol 2000; 73(3):182-188.
28. Breidenbach M, Rein D, Schmidt T, et al. Intra-arterial mitoxantrone and paclitaxel in a patient with Stewart-Treves syndrome: selection of chemotherapy by an ex vivo ATP-based chemosensitivity assay. Anticancer drugs 2000; 11(4):269-273.
29. Fujisawa Y, Ito M, Mori K, et al. Intra-arterial mitoxantrone/paclitaxel in angiosarcoma of the lower limb associated with chronic lymphedema (Stewart-Treves syndrome) in a patient with cervical cancer. Eur J Dermatol 2011; 21(1):119-120.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.